HLS Therapeutics Inc. (TSX:HLS)
Canada
· Delayed Price · Currency is CAD 4.650
+0.010 (0.22%)
Apr 28, 2026, 4:00 PM EST
HLS Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Net Income | -12.43 | -19.66 | -27.53 | -23.6 | -13.12 | Upgrade
|
| Depreciation & Amortization | 21.82 | 22.72 | 31.94 | 34.4 | 30.26 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | -3.38 | - | - | - | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | 3.89 | 3.05 | - | Upgrade
|
| Loss (Gain) From Sale of Investments | - | 0.53 | 2.89 | -2.33 | -1.97 | Upgrade
|
| Stock-Based Compensation | 1.91 | 1.62 | -0.54 | 2.92 | 2.35 | Upgrade
|
| Other Operating Activities | 1.1 | 5.04 | 0.1 | 0.95 | 1.92 | Upgrade
|
| Change in Accounts Receivable | -0.07 | 2.36 | 0.63 | -0.07 | 1.04 | Upgrade
|
| Change in Inventory | 1.28 | -0.19 | -0.66 | -0.62 | 1.77 | Upgrade
|
| Change in Accounts Payable | 0.84 | -4.3 | 1.99 | 3.24 | -3.65 | Upgrade
|
| Change in Income Taxes | 0.33 | -0.11 | 0.39 | -0.29 | -0.45 | Upgrade
|
| Change in Other Net Operating Assets | 2.35 | 3.39 | 2.69 | -0.71 | -1.74 | Upgrade
|
| Operating Cash Flow | 17.13 | 8 | 15.79 | 16.94 | 16.43 | Upgrade
|
| Operating Cash Flow Growth | 114.05% | -49.31% | -6.81% | 3.12% | 75.82% | Upgrade
|
| Capital Expenditures | -0.21 | -0.02 | -0.04 | -0.05 | -0.05 | Upgrade
|
| Cash Acquisitions | - | -1.5 | - | - | - | Upgrade
|
| Sale (Purchase) of Intangibles | -1.5 | 13.25 | -0.15 | -10.1 | -4.46 | Upgrade
|
| Investing Cash Flow | -1.7 | 11.74 | -0.19 | -10.15 | -4.51 | Upgrade
|
| Long-Term Debt Issued | 57.24 | - | - | 10 | - | Upgrade
|
| Long-Term Debt Repaid | -75.61 | -21.57 | -9.46 | -10.44 | -11.14 | Upgrade
|
| Net Debt Issued (Repaid) | -18.37 | -21.57 | -9.46 | -0.44 | -11.14 | Upgrade
|
| Issuance of Common Stock | - | - | 0.13 | 0.18 | 4.91 | Upgrade
|
| Repurchase of Common Stock | -1.8 | -0.6 | -1.55 | -1 | -0.05 | Upgrade
|
| Common Dividends Paid | - | - | -2.4 | -4.96 | -5.12 | Upgrade
|
| Other Financing Activities | -1.39 | -1.19 | -1.36 | -0.64 | - | Upgrade
|
| Financing Cash Flow | -21.56 | -23.36 | -14.64 | -6.86 | -11.4 | Upgrade
|
| Foreign Exchange Rate Adjustments | 0.4 | -0.87 | 0.27 | -0.39 | 0.05 | Upgrade
|
| Net Cash Flow | -5.73 | -4.5 | 1.23 | -0.46 | 0.57 | Upgrade
|
| Free Cash Flow | 16.93 | 7.99 | 15.75 | 16.9 | 16.38 | Upgrade
|
| Free Cash Flow Growth | 111.88% | -49.28% | -6.80% | 3.14% | 76.00% | Upgrade
|
| Free Cash Flow Margin | 30.50% | 14.11% | 24.97% | 27.49% | 27.30% | Upgrade
|
| Free Cash Flow Per Share | 0.54 | 0.25 | 0.49 | 0.52 | 0.51 | Upgrade
|
| Cash Interest Paid | - | - | - | 6.51 | 6.17 | Upgrade
|
| Cash Income Tax Paid | 0.34 | 0.38 | 0.03 | 0.03 | 0.62 | Upgrade
|
| Levered Free Cash Flow | 19.64 | 26.39 | 24.71 | 15.63 | 12.13 | Upgrade
|
| Unlevered Free Cash Flow | 24.08 | 32.69 | 30.18 | 20.2 | 16.47 | Upgrade
|
| Change in Working Capital | 4.73 | 1.14 | 5.04 | 1.55 | -3.02 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.